Chemoinformaics analysis of 13-Hydroxygermacrone
| Molecular Weight | 234.339 | nRot | 1 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 13 |
| Exact Molecular Weight | 234.162 | nRing | 1 |
| Solubility: LogS | -3.986 | nHRing | 0 |
| Solubility: LogP | 3.9 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 41.3234 |
| nHD | 1 | BPOL | 22.9386 |
| QED | 0.394 |
| Synth | 4.105 |
| Natural Product Likeliness | 2.162 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0 |
| HIA | 0.026 |
| CACO-2 | -4.472 |
| MDCK | 0.0000256 |
| BBB | 0.289 |
| PPB | 0.929645 |
| VDSS | 1.827 |
| FU | 0.0382334 |
| CYP1A2-inh | 0.84 |
| CYP1A2-sub | 0.551 |
| CYP2c19-inh | 0.831 |
| CYP2c19-sub | 0.593 |
| CYP2c9-inh | 0.562 |
| CYP2c9-sub | 0.859 |
| CYP2d6-inh | 0.284 |
| CYP2d6-sub | 0.281 |
| CYP3a4-inh | 0.13 |
| CYP3a4-sub | 0.212 |
| CL | 6.436 |
| T12 | 0.422 |
| hERG | 0.004 |
| Ames | 0.239 |
| ROA | 0.059 |
| SkinSen | 0.95 |
| Carcinogencity | 0.943 |
| EI | 0.86 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.057 |
| Antiviral | Yes |
| Prediction | 0.908116 |